Science Progress | Where science, technology, and progressive policy meet

Green Light for Gene Patent Lawsuit

A U.S. District Court judge ruled Monday that a gene patent lawsuit filed against the Patent and Trademark Office could move forward. At issue are patents exclusively licensed by Myriad Genetics for the BRCA1 and BRCA2 genes. Mutations of the [...]

Roundup: ACLU Sues Over Breast Cancer Gene Patents

The American Civil Liberties Union filed suit Tuesday against the U.S. Patent and Trademark Office, Myriad Genetics, and the University of Utah, arguing that patents for the BRCA1 and BRCA2 genes are invalid. Mutations in the two genes are responsible [...]

Weiss On Patent Reform in Boston Globe

The backlog at the United States Patent Office is 1 million applications long. This means that it takes almost 33 months for examiners to decide up or down on an application’s status. For sectors like communications where innovation moves at [...]

INNOVATION

Patent Reform 101

Inventions are being created at an ever-increasing pace and have grown increasingly complex, but the rules governing patents have not seen substantial change in decades. As a result, the system is bogged down, hampering investment and job creation. Here’s how to fix things.

PATENT REFORM

Tackling the Challenge of Patent Reform

Scientific research and technological development have long been mainstays of American economic and military strength. Today more than ever, the global economic crisis and the prospect of a long and deep U.S. recession call for a reinvigoration of America’s scientific, engineering, and manufacturing enterprises.

Enabling Economic Recovery Through Innovation

We will release the Fall/Winter 2008-2009 print edition of Science Progress next Monday, January 12. This issue will feature entirely new content on regional centers of innovation, patent reform, and government contracting of scientific and technological work.

EU Rejects Stem Cell Patent Applications

A colony of undifferentiated human embryonic stem cells.At the end of last week, Reuters reported that the European Patent Office issued its final ruling rejecting a patent application for the stem cell technology based on the work of James Thomson of the University of Wisconsin. Filed in 1995 by the Wisconsin Alumni Research Foundation, the patent, according to the EPO release “describes a method for obtaining embryonic stem cell cultures from primates, including humans.”

In Search of Balance for Intellectual Property Protections

The Senate Finance Committee revisited the problems in international intellectual property rights protection without offering solutions or new points to consider. The conflict between IP protection and the benefits of sharing drugs and technology with developing nations will become even more pertinent as clean energy technologies are perfected.

Older